NASDAQ: HCWBHcw Biologics Inc Stock Ownership - Who owns Hcw Biologics?
Insider buying vs selling
Have Hcw Biologics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Gary M. Winer | Director | 2025-05-16 | 1,342 | $7.45 | $10.00kBuy |
| Scott T. Garrett | Director | 2025-05-16 | 13,423 | $7.45 | $100.00kBuy |
| Hing C. Wong | Chief Executive Officer | 2025-05-16 | 8,054 | $7.45 | $60.00kBuy |
| Rebecca Byam | Chief Financial Officer | 2025-05-08 | 8,462 | $26.00 | $220.01kBuy |
| Gary M. Winer | Director | 2025-05-08 | 2,308 | $26.00 | $60.01kBuy |
| Hing C. Wong | Chief Executive Officer | 2025-05-08 | 92,500 | $26.00 | $2.41MBuy |
| Rick S. Greene | Director | 2025-05-08 | 962 | $26.00 | $25.01kBuy |
| Lee Flowers | SVP of Business Development | 2025-05-08 | 962 | $26.00 | $25.01kBuy |
| Scott T. Garrett | Director | 2025-05-08 | 5,385 | $26.00 | $140.01kBuy |
HCWB insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when HCWB insiders and whales buy or sell their stock.
HCWB Shareholders
What type of owners hold Hcw Biologics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Hing C. Wong | 23.33% | 501,911 | $1.94M | Insider |
| Scott T. Garrett | 13.63% | 293,363 | $1.14M | Insider |
| Peter Rhode | 3.60% | 77,500 | $299.93k | Insider |
| Jinan Jiao | 2.10% | 45,141 | $174.70k | Insider |
| Rebecca Byam | 2.00% | 43,010 | $166.45k | Insider |
| Lisa M. Giles | 1.66% | 35,815 | $138.60k | Insider |
| Golden State Wealth Management LLC | 0.46% | 10,000 | $38.70k | Institution |
| Ubs Group Ag | 0.44% | 9,518 | $36.83k | Institution |
| Lee Flowers | 0.27% | 5,720 | $22.14k | Insider |
| Gary M. Winer | 0.19% | 4,075 | $15.77k | Insider |
HCWB vs Biotech Stocks
Hcw Biologics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.